[18F]fluorocholine PET/CT in the assessment of bone metastases in prostate cancer

被引：0
作者：
Mohsen Beheshti
Reza Vali
Werner Langsteger
机构：
[1] St. Vincent’s Hospital; PET-CT Center LINZ,Department of Nuclear Medicine and Endocrinology
来源：
European Journal of Nuclear Medicine and Molecular Imaging | 2007年 / 34卷
关键词：
Hormone Therapy; Bone Metastasis; Gleason Score; Bone Marrow Involvement; Recurrent Prostate Cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1316 / 1317
页数：1
相关论文
共 27 条
[1]  
Cimitan M(2006)[ Eur J Nucl Med Mol Imaging 33 1387-1398
[2]  
Bortolus R(2006)F]fluorocholine PET/CT imaging for the detection of recurrent prostate cancer at PSA relapse: experience in 100 consecutive patients Semin Nucl Med 36 73-92
[3]  
Morassut S(2006)The role of fluorodeoxyglucose, Mol Imag Biol 8 69-undefined
[4]  
Canzonieri V(2006)F-dihydroxyphenylalanine, Eur J Nucl Med Mol Imaging 33 208-undefined
[5]  
Garbeglio A(2006)F-choline, and Eur J Nucl Med Mol Imaging 33 209-undefined
[6]  
Baresic T(undefined)F-fluoride in bone imaging with emphasis on prostate and breast undefined undefined undefined-undefined
[7]  
Langsteger W(undefined)Fluor choline (FCH) positron emission tomography/computed tomography in preoperative staging and follow up of prostate cancer patients undefined undefined undefined-undefined
[8]  
Heinisch M(undefined)Assessment of bone metastases in patients with prostate cancer by dual-phase F-18 fluor choline PET/CT undefined undefined undefined-undefined
[9]  
Fogelman I(undefined)Evaluation of lymph node and bone metastases with fluor choline (FCH) PET-CT in the follow up of prostate cancer patients undefined undefined undefined-undefined
[10]  
Langsteger W(undefined)undefined undefined undefined undefined-undefined
123